Pricing Log in Create free account
Saturday 17 October 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

104.88 0.20 +0.19%
Market cap
$181.1B
P/E
33.9×
Fwd P/E
22.9×
Dividend yield
2.40%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Abbott Laboratories (ABT) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, Abbott Laboratories (ABT) trades at a EV/EBITDA of 19.4×. Over the past ten years it has ranged from 12.1× (September 2015) to 29.5× (August 2020); the current reading is higher than 39% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 19.9× (1.60%)
FY2024 20.2× (1.05%)
FY2023 20.4× 19.53%
FY2022 17.1× (20.66%)
FY2021 21.5× (9.01%)
FY2020 23.7× 6.70%
FY2019 22.2× 8.38%
FY2018 20.5× (6.57%)
FY2017 21.9× 67.03%
FY2016 13.1× (14.99%)

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 17.1× (9.44%)
Mar 2026 18.9× (4.85%)
Dec 2025 19.9× (9.60%)
Sep 2025 22.0× (3.64%)
42 more quarters

Against its own ten years

Low 12.1× High 29.5×
Ten-year median 20.3×
Current reading's percentile 39

EV/EBITDA against peers

Company EV/EBITDA
PHG Koninklijke Philips N.V. compare 8.8×
GEHC GE HealthCare Technologies Inc. compare 12.3×
BSX Boston Scientific Corporation compare 13.9×
STE STERIS plc compare 14.2×
MDT Medtronic PLC compare 14.5×
SYK Stryker Corporation compare 18.4×
ABT Abbott Laboratories 19.4×
DXCM DexCom, Inc. compare 23.5×
EW Edwards Lifesciences Corporation compare 29.0×
Medical Devices industry median 11.5×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ABT